The SOPHiA DDM™ Platform will help Laboratorio Curie advance its research into BRCA gene mutations BOSTON and ROLLE, Switzerland — Sophia Genetics (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, has expanded its relationship with Laboratorio Curie, a leading laboratory located in the capital city of Paraguay. Laboratorio Curie is now live on the SOPHiA DDM™ Platform […]
Cambridge – Congenica, a leading digital health company specialising in the provision of software and solutions for genomic data analysis and interpretation, and myTomorrows, a global platform facilitating access to pre-approval treatments and clinical trials, have partnered to expedite access to precision oncology for cancer patients worldwide. The partnership between Congenica and myTomorrows will open […]
Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors MOUNTAIN VIEW, Calif., — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief […]
API gives easier access to QIAGEN Biomedical Knowledge Base, used by over 40,000 researchers Structured content from over 20 years of curation has been cited in over 57,000 scientific papers Enables large and small pharma and biotech companies to access vital data for drug discovery and other insights Venlo, the Netherlands, and Redwood City, California […]
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Dr. Ben M. W. Illigens, an experienced clinician and neuroscientist, as the company’s Chief Medical Officer. BCP’s CMO will be overseeing the operational work underpinning the company’s rapidly expanding global patient data sourcing and data network development, which provides […]
With the help of the SOPHiA DDM™ Platform, IRST has introduced a new diagnostic kit that will support data-driven treatment planning for advanced ovarian cancer BOSTON, USA and ROLLE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, is helping excel the use of precision medicine to treat advanced ovarian […]
Espoo, Finland. Euformatics, a world leader in NGS quality control and variant interpretation tools, announced that it has signed a new commercial relationship with Cerba, world reference laboratory in specialized clinical pathology. As part of the collaboration, Euformatics delivers the full Genomics Hub software suite to Cerba to power their NGS test validation, continuous quality […]
The hospital is using the SOPHiA DDM™ Platform to advance the research of Homologous Recombination Repair Mutated Cancers BOSTON and ROLLE — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that CHU Bordeaux, a full-service hospital servicing the population of Bordeaux and the surrounding area, has completed implementation of […]
Gustave Roussy uses SOPHiA DDM™ Platform to empower confident, data-driven medicine in the fight against cancer BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with Gustave Roussy, the leading cancer center in Europe. With the expanded relationship SOPHiA GENETICS will now further […]
The School of Medicine will use the SOPHiA DDM™ Platform to expand its hematologic testing program for blood cancers BOSTON and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Tulane University School of Medicine in New Orleans, Louisiana is live on SOPHiA GENETICS technology. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
